Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-05-2009 | Focus on

Nanoparticles for concurrent multimodality imaging and therapy: The dawn of new theragnostic synergies

Author: Giovanni Lucignani

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2009

Excerpt

“All science is interdisciplinary–from magnetic moments to molecules to men” [1]

Paul C. Lauterbur (1929-2007)

…

Lauterbur PC. Nobel Lecture. All science is interdisciplinary–from magnetic moments to molecules to men. Biosci Rep 2004;24(3):165–78.PubMedCrossRef

Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17(5):545–80.PubMedCrossRef

Alric C, Taleb J, Le Duc G, Mandon C, Billotey C, Le Meur-Herland A, et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J Am Chem Soc 2008;130(18):5908–15.PubMedCrossRef

McCarthy JR, Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008;60(11):1241–51.PubMedCrossRef

Shokeen M, Fettig NM, Rossin R. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles. Q J Nucl Med Mol Imaging 2008;52(3):267–77.PubMed

Cheon J, Lee JH. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res 2008;41(12):1630–40.PubMedCrossRef

Ducongé F, Pons T, Pestourie C, Hérin L, Thézé B, Gombert K, et al. Fluorine-18-labeled phospholipid quantum dot micelles for in vivo multimodal imaging from whole body to cellular scales. Bioconjug Chem 2008;19(9):1921–6.PubMedCrossRef

Chen K, Li ZB, Wang H, Cai W, Chen X. Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots. Eur J Nucl Med Mol Imaging 2008;35(12):2235–44.PubMedCrossRef

Devaraj NK, Keliher EJ, Thurber GM, Nahrendorf M, Weissleder R. ¹⁸F Labeled Nanoparticles for in Vivo PET-CT Imaging. Bioconjug Chem. 2009 Jan 12. [Epub ahead of print]. doi: 10.1021/bc8004649.

10.

Flexman JA, Cross DJ, Lewellen BL, Miyoshi S, Kim Y, Minoshima S. Magnetically targeted viral envelopes: a PET investigation of initial biodistribution. IEEE Trans Nanobioscience 2008;7(3):223–32.PubMedCrossRef

11.

Lee HY, Li Z, Chen K, Hsu AR, Xu C, Xie J, et al. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med 2008;49(8):1371–9.PubMedCrossRef

12.

Jarrett BR, Gustafsson B, Kukis DL, Louie AY. Synthesis of ⁶⁴Cu-labeled magnetic nanoparticles for multimodal imaging. Bioconjug Chem 2008;19(7):1496–504.PubMedCrossRef

13.

Cormode DP, Skajaa T, van Schooneveld MM, Koole R, Jarzyna P, Lobatto ME, et al. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett 2008;8(11):3715–23.PubMedCrossRef

14.

Mulder WJ, Cormode DP, Hak S, Lobatto ME, Silvera S, Fayad ZA. Multimodality nanotracers for cardiovascular applications. Nat Clin Pract Cardiovasc Med 2008;5(Suppl2):103–11.CrossRef

15.

van Schooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, Cormode DP, et al. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett 2008;8(8):2517–25.PubMedCrossRef

16.

Koole R, van Schooneveld MM, Hilhorst J, Castermans K, Cormode DP, Strijkers GJ, et al. Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjug Chem 2008;19(12):2471–9.PubMedCrossRef

17.

Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomed 2008;3(5):703–17.PubMedCrossRef

18.

Boerman OC, Oyen WJ. Multimodality probes: amphibian cars for molecular imaging. J Nucl Med 2008;49(8):1213–4.PubMedCrossRef

Title: Nanoparticles for concurrent multimodality imaging and therapy: The dawn of new theragnostic synergies
Author: Giovanni Lucignani
Publication date: 01-05-2009
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2009
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-009-1104-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Nanoparticles for concurrent multimodality imaging and therapy: The dawn of new theragnostic synergies

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2009

Diagnostics of “non-acute” vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses

Serotonin transporter binding with [123I]β-CIT SPECT in major depressive disorder versus controls: effect of season and gender

18F-Fluorodeoxyglucose and PET/CT for noninvasive study of exercise-induced glucose uptake in rat skeletal muscle and tendon

Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP

Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease